CANC Holdings Information

CANC is an equity ETF with a total of 57 individual holdings. The top holdings are Revolution Medicines stock at 7.28%, Novartis AG at 4.62%, Eli Lilly and Company at 4.52%, AstraZeneca at 4.35%, and BridgeBio Pharma at 4.25%.

Total Holdings

Top 10 Percentage

43.39%

Asset Class

Equity

ETF Category

Health

Assets

139.44M

PE Ratio

19.80

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	7.28%	83,600
2	SWX: NOVN	Novartis AG	4.62%	44,358
3	LLY	Eli Lilly and Company	4.52%	5,862
4	LON: AZN	AstraZeneca PLC	4.35%	31,419
5	BBIO	BridgeBio Pharma, Inc.	4.25%	75,970
6	RHHBY	Roche Holding AG	3.98%	102,770
7	MRK	Merck & Co., Inc.	3.87%	48,521
8	GMAB	Genmab A/S	3.83%	150,924
9	BMY	Bristol-Myers Squibb Company	3.43%	83,878
10	COGT	Cogent Biosciences, Inc.	3.27%	120,365
11	NUVL	Nuvalent, Inc.	3.19%	41,254
12	EXEL	Exelixis, Inc.	3.02%	92,868
13	AMGN	Amgen Inc.	2.73%	11,553
14	JNJ	Johnson & Johnson	2.69%	17,168
15	CELC	Celcuity Inc.	2.59%	31,470
16	ABBV	AbbVie Inc.	2.34%	14,671
17	ONC	BeOne Medicines AG	2.27%	9,123
18	IMNM	Immunome, Inc.	2.24%	150,238
19	ACLX	Arcellx, Inc.	2.23%	44,506
20	IDYA	IDEAYA Biosciences, Inc.	2.11%	79,368
21	SNDX	Syndax Pharmaceuticals, Inc.	1.74%	113,253
22	LEGN	Legend Biotech Corporation	1.72%	102,625
23	CGON	CG Oncology, Inc.	1.63%	40,809
24	ZYME	Zymeworks Inc.	1.52%	86,007
25	HALO	Halozyme Therapeutics, Inc.	1.50%	28,556

Showing 25 of 57 holdings

Subscribe to see the full list

Activate Now

As of Jan 14, 2026